4727 West Second Avenue
Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules that can block self-attack due to abnormal activation of the body’s own complement system. Such attack has been reported to occur in a wide spectrum of conditions where disease-modifying treatments are urgently need.
CEO: Patrick L. McGeer
Please click here for clinical trial information.